Cosmo Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 4/6
Cosmo Pharmaceuticals is a dividend paying company with a current yield of 2.97% that is well covered by earnings.
Key information
3.0%
Dividend yield
0.1%
Buyback Yield
| Total Shareholder Yield | 3.1% |
| Future Dividend Yield | 1.4% |
| Dividend Growth | 16.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CHF 2.000 |
| Payout ratio | 46% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 0RGI's dividend payments have been volatile in the past 10 years.
Growing Dividend: 0RGI's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Cosmo Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (0RGI) | 3.0% |
| Market Bottom 25% (GB) | 2.1% |
| Market Top 25% (GB) | 5.9% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (0RGI) (up to 3 years) | 1.4% |
Notable Dividend: 0RGI's dividend (2.97%) is higher than the bottom 25% of dividend payers in the UK market (2.11%).
High Dividend: 0RGI's dividend (2.97%) is low compared to the top 25% of dividend payers in the UK market (5.87%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (46.2%), 0RGI's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (32.8%), 0RGI's dividend payments are well covered by cash flows.